Albany Molecular Research has the Highest EBITDA Growth in the Life Sciences Tools & Services Industry (AMRI, AFFX, BRKR, PRXL, PKI)
Below are the three companies in the Life Sciences Tools & Services industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.
Albany Molecular Research ranks highest with a EBITDA growth of 174.8%. Affymetrix is next with a EBITDA growth of 66.7%. Bruker ranks third highest with a EBITDA growth of 53.8%.
Parexel International follows with a EBITDA growth of 47.0%, and PerkinElmer rounds out the top five with a EBITDA growth of 38.6%.
SmarTrend recommended that its subscribers protect gains by selling shares of Bruker on May 18th, 2016 by issuing a Downtrend alert when the shares were trading at $26.10. Since that call, shares of Bruker have fallen 14.2%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.
Keywords: highest ebitda growth albany molecular research Affymetrix bruker parexel international perkinelmer